Nutex Health (NUTX) Stock Price

Nutex Health Price

NASDAQ·CLOSED
213.02
​
Market closed

Over the last 16 years Nutex Health grew revenue by 67.9% annually, reaching 875.26 M USD. Earnings per share have grown at 35.3% per year over the last 17 years. For Nutex Health, the net margin of 8.1% is down versus 40.0% a few years ago. The consensus 12-month price target for Nutex Health is 310.00 USD, about 45.5% above where the stock trades today. Of 11 analysts, 10 rate the stock a buy — an overall Buy consensus.

Nutex Health stock price

Access this data via the Eulerpool API

Nutex Health business model & stock analysis

Nutex Health, Inc. operates technology-enabled healthcare services. The company is headquartered in Houston, Texas and currently employs 800 full-time employees. The company went IPO on 2011-03-18. The firm operates through two divisions: the Hospital division and Population Health Management division. The Hospital division owns and operates approximately 22 facilities in eight different states. The Company’s Hospital division implements and operates different health care models, including micro-hospitals, specialty hospitals, and hospital outpatient departments (HOPDs). The Population Health Management division owns and operates provider networks, such as Independent Physician Associations (IPAs). Through its Management Services Organizations (MSOs), the Company provides management, administrative, and other support services to its affiliated hospitals and physician groups. The firm's cloud-based technology platform aggregates clinical and claims data across multiple settings, information systems, and sources to create a holistic view of patients and providers.

Frequently asked questions about Nutex Health

Analysts currently set an average price target of 310.00 USD for the Nutex Health stock (median: 310.00 USD), implying +45.5 % versus the latest price. The consensus is based on 11 analyst ratings.

11 analysts currently rate the Nutex Health stock: 10 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Nutex Health to generate revenue of 872.02 M USD and earnings per share of 27.38 USD.

Converted at the current exchange rate, the Nutex Health share trades at 190.07 EUR (213.02 USD).

The Nutex Health share (NUTX) is listed on 1 stock exchanges, including: NASDAQ (NUTX).

The expected revenue of Nutex Health is 872.02 M USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Nutex Health is 196.50 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Nutex Health is currently 7.78. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Nutex Health stock.

The price-to-sales ratio (P/S) of Nutex Health is currently 1.75. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Nutex Health stock.

The Eulerpool Quality Score for Nutex Health is 4/10.

The ISIN of Nutex Health is US67079U3068. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Nutex Health is NUTX. The ticker symbol is used to trade Nutex Health shares on the stock exchange.

Fair ValueTerminal
202.37 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Providers & Services
Number of shares
Employees
Revenue per Employee
927,179.03 USD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Currency
USD
Initial public offering
Mar 18, 2011
ISIN
US67079U3068
Cusip
67079U108
Market capitalization
1.51 B USDSmall Cap
52-Week Range
PEG
-7.12
P/E ratio
P/Ee 2026
7.66
P/Ee 2027
7.64
P/Ee 2028
8.41
P/S
P/Se
1.75
EV/EBIT
6.07
P/B Ratio
4.57
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
10.40 %
Last updated Oct 9, 2026, 8:03 AM

Nutex Health Peer Group

Nutex Health Ticker

NASDAQ · NUTX

All fundamentals and in-depth analysis of Nutex Health

Our stock analysis for Nutex Health stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Nutex Health. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.